Achilles therapeutics co-founder professor charles swanton to participate in expert roundtable highlighting pivotal nature of neoantigens as targets in cancer cell therapy

Professor swanton joins achilles sab member dr. christopher klebanoff and dr. john haanen on the key opinion leader panel to discuss neoantigens as valuable immunotherapy targets
ACHL Ratings Summary
ACHL Quant Ranking